Skip to main content

Table 1 Baseline subjects demographics & characteristics

From: The impact of a disease management program (COACH) on the attainment of better cardiovascular risk control in dyslipidaemic patients at primary care centres (The DISSEMINATE Study): a randomised controlled trial

 

Intervention Arm (n=149)

Control Arm (n=145)

Number of subjects; n (%)

   Male

86 (57.7%)

83 (57.2%)

   Female

63 (42.3%)

62 (42.8%)

Age, years; Mean (SD)

49.4 (11.1)

48.8 (9.9)

Race; Asian

149 (100.0)

145 (100.0)

Weight, kg; Mean(SD)

72.7 (15.2)

70.2 (15.1)

Height, cm; Mean (SD)

160.2 (8.2)

159.6 (9.3)

Body mass index, kg/m2; Mean (SD)

28.2 (4.9)

27.4 (4.9)

Mean duration of dyslipidaemia since onset (years)

0.6

0.6

Cardiovascular risk group a; n (%)

   Group I

14 (9.4)

24 (16.6)

   Group II

87 (58.4)

74 (51.0)

   Group III

48 (32.2)

47 (32.4)

Age risk; n (%)

   Male aged >45; Female aged >55

72 (48)

60 (41)

   Male aged ≤45; Female aged ≤55

77 (52)

85 (59)

Family history b; n (%)

   Yes

29 (19)

32 (22)

   No

120 (81)

113 (78)

Blood pressure ≥ 140/90 mm Hg or antihypertensive medication at baseline; n (%)

   Yes

89 (60)

88 (61)

   No

60 (40)

57 (39)

Diabetes Mellitus; n (%)

   Yes

47 (32)

47 (32)

   No

102 (68)

98 (68)

CHD or CHD risk equivalent a; n (%)

   Yes

1 (1)

1 (1)

   No

148 (99)

144 (99)

Smoking Status

   Never smoked

101 (68)

97 (67)

   Ex-smoker

13 (9)

19 (13)

   Current smoker

35 (23)

29 (20)

  1. COACH = Counselling and Advisory Care for Health; SD = standard deviation; CHD = coronary heart disease; PCP = Primary Care Physicians; PCP-NE = Primary Care Physicians assisted by Nurse Educators.
  2. a Group I: subjects with dyslipidaemia with no other cardiovascular risk factors; Group II: subjects with dyslipidaemia with at least 1 additional cardiovascular risk factor, excluding CHD and DM; Group III: subjects with dyslipidaemia with CHD or CHD risk equivalent.
  3. b A history of premature coronary heart disease in a first-degree relative (parent or sibling). If the afflicted family member was male, premature coronary heart disease would have occurred before age 55, and if female, before age 65.